Capstone Investment Advisors, LLC Novavax Inc Put Options Transaction History

Capstone Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $70,020 - $377,460	18,000 Added 83.33%	39,600 $501,000
Q1 2024 May 01, 2024	SELL	$3.76 - $6.02 $1.57 Million - $2.51 Million	-417,000 Reduced 95.08%	21,600 $103,000
Q4 2023 Feb 12, 2024	BUY	$4.8 - $7.67 $480 - $767	100 Added 0.02%	438,600 $2.11 Million
Q2 2023 Aug 10, 2023	BUY	$6.67 - $9.52 $1.37 Million - $1.95 Million	204,700 Added 87.55%	438,500 $3.26 Million
Q1 2023 May 09, 2023	BUY	$5.76 - $12.48 $1.35 Million - $2.92 Million	233,800 New	233,800 $1.62 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.